News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ACCU-BREAK Pharmaceuticals, Inc. Announces European Cooperation Agreement with Midas Pharma GmbH


2/20/2008 9:08:06 AM

PLANTATION, Fla.--(BUSINESS WIRE)--Accu-Break Pharmaceuticals, Inc. (“ABP”), a company with a suite of pharmaceutical tablet technologies for creating divisible dosage forms (the “Accu-Break™ Technologies”) and Midas Pharma GmbH (“Midas”), an independent marketing and distribution company, which supports clients and manufacturing partners regarding all questions concerning Active Pharmaceutical Ingredients, Biosimilars, Custom Synthesis, Contract Manufacture, International Licensing and Pharmaceutical Dossiers, announced today the signing of a cooperation agreement.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES